VEGFR contributes to tumor angiogenesis by binding to VEGF, which activates the receptor’s tyrosine kinase activity. This activation triggers a cascade of downstream signaling pathways that stimulate endothelial cell proliferation, migration, and the formation of new blood vessels. Tumors often secrete high levels of VEGF, leading to excessive activation of VEGFR and abnormal blood vessel formation.
